IMMUNIZATION OF CHILDREN USING VACCINE AGAINST MORBILE, MUMPS AND RUBELLA, IN TUZLA CANTON: FIVE YEARS REVIEW

Authors

  • Zlata Salihović Zorić Faculty of Medicine University of Tuzla, Bosnia and Herzegovina https://orcid.org/0000-0002-3571-704X
  • Amer ćustović University Clinical Center Tuzla, Bosnia and Herzegovina
  • Fatima Numanović University Clinical Center Tuzla, Bosnia and Herzegovina
  • BlaÅ¡ko Topalović Institute of Public Health of Tuzla Canton

DOI:

https://doi.org/10.5457/ams.v51i1-2.562

Keywords:

immunization, MMR vaccine, prevention

Abstract

Introduction: Vaccines are biological preparations that allow the formation of anti-bodies in the human body, while preparing the immune system to fight infection. The goal of vaccination is to produce enough antibodies to provide long-term protection against the disease. Currently, there is a growing trend in the world of non-vaccination of children, and therefore a drop in coverage below the expected 95%. This trend is mostly related to the vaccine against measles,mumps and rubella  (MMR). The decline is noticeable throughout BiH, as well as in the countries of the region and the European Union. Method: The main objective of the study is to determine the percentage coverage of the target group with two doses of MMR vaccine per year and municipalities in the Tuzla Canton (TC). The survey is retrospective in nature and covers the period from 01.01.2013. until 31.12.2017. The target group is children from 5 to 6 years of age.

Results: The overall coverage rate of the target group with two doses of MMR vaccine in the TC area by years is 82.0% (2013), 83.7% (2014), 78.8% (2015), 73.0% (2016) and 67.2% (2017). So, from the coverage of 82.0% achieved in 2013, the rate is constantly declining and reaching the value of 67.2% in 2017, which is 14.8% lower. Research shows that the coverage of MMR vaccine in the area of TC is not satisfactory, and the most critical municipalities are Lukavac, Banovici, Sapna, Tuzla, Gracanica and Kalesija.

Conclusion: The key strategic directions for prevention are maintaining a high coverage rate (≥ 95%) with two doses of MMR vaccine, then creating conditions for vaccination in unvaccinated or under-vaccinated population groups, and strengthening surveillance systems and increasing the availability of information for to the general public on the benefits of MMR immunization. The decline in the quality of the population's collective immunity against certain infectious diseases greatly threatens the recurrence of sporadic or epidemic outbreaks.

 

Downloads

Published

2022-03-23

Issue

Vol. 51 No. 1-2 (2021)

Section

Original papers

License

Copyright transfer

The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.